Advancing biomarker strategies in atopic dermatitis

Atopic dermatitis (AD) takes a significant emotional and physical toll, with flare-ups often measured using subjective scoring methods. The new SCCA2 assay offers a way to shift toward more objective, data-driven insights.

In this 7-minute webinar, you'll get a quick overview of:

• The epidemiology of atopic dermatitis
• How SCCA2 functions as a biomarker in AD’s inflammatory process
• The role of SCCA2 in enabling objective measurement
• Market opportunities for this diagnostic approach

Learn more about the SCCA2 ELISA, an easy-to-use blood test that brings measurable clarity to AD monitoring: https://ibl-international.com/en/30256207-scca2-elisa